Trans-Oral Robotic Surgery (TORS) in Morocco – A minimally invasive approach to modern ENT

Trans-oral robotic surgery (TORS) represents a revolution in the treatment of deep ENT pathologies, particularly in the throat and base of tongue.

It allows intervention through the mouth, without opening the neck, thanks to a high-precision surgical robot, with considerable benefits: less pain, no external scar, and rapid recovery.

Our ENT center in Morocco is one of the few to offer this innovative technique, particularly for benign conditions and certain early oropharyngeal tumors, with complete and safe care.

TORS is a minimally invasive surgical technique that involves accessing certain difficult-to-reach areas of the throat through the mouth, without external incision, using a surgical robot (typically the Da Vinci® system). The surgeon controls the robot from a console, operating with:

  • Miniature articulated instruments.
  • High-definition 3D vision.
  • Extreme precision in movements.
Trans-oral robotic surgery is particularly indicated for:
  • Early oropharyngeal tumors (tonsil, base of tongue, soft palate).
  • Cysts or benign lesions of the deep throat.
  • Severe sleep apnea syndrome (in case of base of tongue reduction).
  • Targeted biopsies of difficult-to-access masses.
  • Treatment of HPV-induced cancers (oropharyngeal cancers).
NB: Not all pathologies are accessible through the trans-oral route. A precise assessment is essential to evaluate the indication.
  • State-of-the-art technical platform (dedicated surgical robot).
  • Team specialized in ENT robotic surgery.
  • Experience in HPV+ cancer pathologies.
  • Comprehensive care: diagnosis, surgery, post-operative follow-up.
  • Care for Moroccan and international patients.
  •  

The advantages of trans-oral robotic surgery

Procedure and post-operative course

After trans-oral robotic surgery (TORS), the patient is placed in the post-operative recovery room to ensure safe initial recovery. Pain is generally moderate and well controlled with simple pain medication.

Resumption of eating is gradual and can begin within the first 24 to 48 hours, depending on patient comfort. Hospitalization is short, ranging from one to three days in most cases. A complete return to daily activities is generally possible between 10 and 15 days after the procedure, depending on clinical progress and any specific recommendations from the surgeon.

Although TORS is a minimally invasive technique offering many advantages, it is not entirely without risks. Possible complications include local bleeding (rare but to be monitored), temporary throat pain, or localized infection.

It is also common to experience temporary swallowing discomfort while the tissues heal completely. In cases of cancer surgery, complementary treatment — such as radiotherapy — may be indicated depending on the results of the pathological analysis. Rigorous and personalized follow-up is provided to anticipate and treat any potential complications.